PROS1 and influenza: To produce an effective bivalent vaccine against both SARS-CoV-2 and influenza, we expressed recombinant antigens in plants and used BLP as a vehicle to deliver the recombinant antigens, the S protein of SARS-CoV-2, and the HA of influenza during vaccination.